EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 205 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -30.8% | 185 | -13.1% | 0.00% | 0.0% |
| Q4 2018 | $13,000 | +44.4% | 213 | +52.1% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -87.0% | 140 | -91.8% | 0.00% | -83.3% |
| Q3 2017 | $69,000 | +27.8% | 1,700 | +6.2% | 0.01% | +20.0% |
| Q2 2017 | $54,000 | -79.8% | 1,600 | -82.6% | 0.01% | -80.8% |
| Q1 2017 | $267,000 | -29.2% | 9,183 | -20.0% | 0.03% | -43.5% |
| Q4 2016 | $377,000 | +61.8% | 11,481 | +55.3% | 0.05% | +91.7% |
| Q3 2016 | $233,000 | +80.6% | 7,393 | +61.6% | 0.02% | +33.3% |
| Q2 2016 | $129,000 | -32.8% | 4,576 | -13.2% | 0.02% | -33.3% |
| Q1 2016 | $192,000 | +163.0% | 5,274 | +137.1% | 0.03% | +170.0% |
| Q2 2015 | $73,000 | +78.0% | 2,224 | +48.3% | 0.01% | +66.7% |
| Q4 2014 | $41,000 | -70.9% | 1,500 | -77.3% | 0.01% | -70.0% |
| Q3 2014 | $141,000 | +2.9% | 6,600 | +8.2% | 0.02% | +11.1% |
| Q2 2014 | $137,000 | +953.8% | 6,100 | +1120.0% | 0.02% | +800.0% |
| Q1 2014 | $13,000 | +116.7% | 500 | +47.1% | 0.00% | +100.0% |
| Q3 2013 | $6,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |